Researchers identify 73 novel variants of coronavirus strain in Odisha

The researchers are from CSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi and Institute of Medical Sciences and SUM Hospital, Bhubaneswar

Coronavirus, Coronavirus tests
A healthcare worker wearing Personal Protective Equipment (PPE) collects a sample using a swab from a woman to conduct tests for Coronavirus diseases (COVID-19) amid the spread of the disease in New Delhi on Friday.
Press Trust of India Bhubaneswar
2 min read Last Updated : Aug 15 2020 | 12:19 PM IST

A team of genomic

researchers from two institutes has identified 73 novel variants of the COVID-19 strain in Odisha, its head has said.

The researchers are from CSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi and Institute of Medical Sciences and SUM Hospital, Bhubaneswar, he said.

"The research team, which carried out sequencing of 1,536 samples including 752 clinical samples, reported two lineages -- B.1.112 and B.1.99 -- for the first time in India," Dr Jayashankar Das, lead investigator and director (research) of the IMS and SUM Hospital, said on Friday.

If one gets to know the detailed character of the novel coronavirus, it will be very easy to treat patients and cure them, he said.

The research team, supported by the Council of Scientific and Industrial Research (CSIR), validated the most-advanced COVID-19 sequencing technology. This could be a potential high-sensitivity assay for the detection of SARS- CoV-2 with the additional advantage of enabling genetic epidemiology of SARS-CoV-2, Das said.

With this study, India has beaten 12 organisations in 10 countries to complete the first field validation and release the data online, he said, quoting a report by sequencing tech giant Illumina.

The IMS and SUM Hospital researchers are also undertaking the sequencing and analysis of 500 viral genomes to understand the mild, moderate and critical coronavirus infection along with its transmission capabilities, he said.

Besides, the study will help understand the vulnerability of the strains, new therapeutic target and new mutation in eastern India, especially in Odisha, Das said.

The rapid emergence of COVID-19 as a pandemic, which has affected millions of people across the world, has necessitated sensitive and high-throughput approaches for the diagnosis, surveillance and determining the genetic epidemiology of SARS-CoV-2, which will help in tracking strain information as well, he said.

Asked about the difference between RT-PCR test and COVID-19 sequencing tests, Das said, "The COVID-19 sequencing reports give the entire history of the coronavirus, while the RT-PCR tests only determine whether a patient is positive or negative for the infection.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus TestsCoronavirus VaccineHealth Ministry

First Published: Aug 15 2020 | 12:09 PM IST

Next Story